Article info
PDFEditors’ commentary
Highlights from this issue
- Correspondence to Dr Geraint N Fuller, Gloucester Royal Hospital, Gloucester GL1 3NN, UK; geraint.fuller{at}nhs.net
Citation
Highlights from this issue
Publication history
- Received October 11, 2018
- Accepted October 11, 2018
- First published November 16, 2018.
Online issue publication
November 17, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Medicine and the rise of the robots: a qualitative review of recent advances of artificial intelligence in health
- Artificial intelligence (AI) for neurologists: do digital neurones dream of electric sheep?
- Machine learning in cardiovascular medicine: are we there yet?
- Artificial intelligence and inflammatory bowel disease: practicalities and future prospects
- Big data, machine learning and artificial intelligence: a neurologist’s guide
- Glaucoma management in the era of artificial intelligence
- Use of artificial intelligence in imaging in rheumatology – current status and future perspectives
- Governing the safety of artificial intelligence in healthcare
- Understanding and interpreting artificial intelligence, machine learning and deep learning in Emergency Medicine
- Improving Skin cancer Management with ARTificial Intelligence (SMARTI): protocol for a preintervention/postintervention trial of an artificial intelligence system used as a diagnostic aid for skin cancer management in a specialist dermatology setting